or Try an Advanced Search...

    Technical Analysis for PRCT - PROCEPT BioRobotics Corporation

    Grade Last Price % Change Price Change
    B 69.19 5.94% 3.88
    PRCT closed up 5.94 percent on Wednesday, May 15, 2024, on 1.72 times normal volume. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    Earnings due: Jun 4
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical PRCT trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    New 52 Week Closing High Bullish 0.00%
    Expansion Breakout Bullish Swing Setup 0.00%
    Wide Range Bar Range Expansion 0.00%
    New 52 Week High Strength 0.00%
    Multiple of Ten Bearish Other 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Older End-of-Day Signals for PRCT ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 13 hours ago
    New 52 Week High about 13 hours ago
    Rose Above Upper Bollinger Band about 13 hours ago
    Up 5% about 13 hours ago
    Up 3% about 13 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PRCT Chart by TradingView
    Basic chart:

    Profile

    PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Medicine Clinical Medicine IBD 50 Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery

    Is PRCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
    May 6 Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
    May 4 PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price Targets
    May 3 PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript
    May 3 PROCEPT BioRobotics First Quarter 2024 Earnings: Beats Expectations
    May 1 Procept GAAP EPS of -$0.51 beats by $0.04, revenue of $44.5M beats by $2.83M
    May 1 Procept GAAP EPS of -$0.51, revenue of $44.5M
    May 1 PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript
    May 1 Biotech Leader Procept BioRobotics Jumps Past Buy Point On Earnings
    May 1 PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
    See more PRCT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 77.0
    52 Week Low 24.83
    Average Volume 579,131
    200-Day Moving Average 41.34
    50-Day Moving Average 52.62
    20-Day Moving Average 58.14
    10-Day Moving Average 63.43
    Average True Range 3.61
    RSI (14) 74.75
    ADX 37.37
    +DI 44.70
    -DI 6.25
    Chandelier Exit (Long, 3 ATRs) 66.16
    Chandelier Exit (Short, 3 ATRs) 59.34
    Upper Bollinger Bands 69.89
    Lower Bollinger Band 46.38
    Percent B (%b) 0.97
    BandWidth 40.45
    MACD Line 4.07
    MACD Signal Line 3.27
    MACD Histogram 0.7959
    Fundamentals Value
    Market Cap 3.49 Billion
    Num Shares 50.5 Million
    EPS -2.33
    Price-to-Earnings (P/E) Ratio -29.70
    Price-to-Sales 21.67
    Price-to-Book 8.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 86.39
    Resistance 3 (R3) 87.09 82.04 83.53
    Resistance 2 (R2) 82.04 77.66 81.70 82.57
    Resistance 1 (R1) 75.62 74.95 78.83 74.92 81.62
    Pivot Point 70.57 70.57 72.18 70.23 70.57
    Support 1 (S1) 64.15 66.19 67.36 63.46 56.76
    Support 2 (S2) 59.10 63.48 58.76 55.81
    Support 3 (S3) 52.68 59.10 54.85
    Support 4 (S4) 51.99